A more detailed evaluation of Lp(a) levels showed that Lp(a) levels are significantly increased in the group of cases with CVI and in individuals with a myocardial infarction, whereas this trend is observed in individuals with peripheral arterial diseases, however without reaching statistical significance (Figure 2a,d,g). The gene discussed is LPA; the disease is peripheral arterial disease.